Meso Numismatics secures up to $10M equity financing from GHS Investments

Regenerative Medical Technology Group Inc.

GHS will purchase shares at 80% of market price (90% after up-list); puts up to $700K each over 24 months.
Company issued 50,000 commitment shares to GHS; also pays 2% placement agent fee to Icon Capital.
Beneficial ownership capped at 4.99%; no short selling by GHS; requires effective registration statement.
Company must file S-1 within 30 days; proceeds for general corporate purposes; stock traded on OTC.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Regenerative Medical Technology Group Inc. entered into Equity Financing Agreement with GHS valued at up to $10,000,000 (effective 2023-12-08).

Action: entry
Agreement: equity purchase
Counterparty: GHS
Value: up to $10,000,000
Effective: 2023-12-08

Exact text from the filing

On December 8, 2023, we entered into an Equity Financing Agreement (the “Financing Agreement”) and Registration Rights Agreement with GHS.

View on SEC.gov

Browse all material agreements →

Regenerative Medical Technology Group Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-095384

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.